LBRX
LB Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
LBRX Filings
Filing Date
Form Description
Form Type
2026-02-05
Form 8-K - Current report
Key Events
2026-02-05 · Key Events
Form 8-K - Current report
2026-01-21
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-31
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-31 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-11
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-11 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2025-11-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
